Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs

Lancet. 1976 Apr 17;1(7964):821-5. doi: 10.1016/s0140-6736(76)90477-3.

Abstract

Insulin, glucagon, and insulin/glucagon mixtures have been infused for four days into the left portal vein of dogs after portacaval shunt. In the left but not in the right liver lobes, insulin alone reduced atrophy, preserved hepatocyte ultrastructure, and trebled cell renewal. Glucagon alone had no effect. In small doses, glucagon did not potentiate the action of insulin and in large doses it may have reduced the insulin benefit. These studies explain the development of the previously mysterious Eck fistula syndrome, provide clues about in-vivo cell growth control by hormones, and suggests new lines of inquiry about the pathogenesis and/or treatment of several human disease processes.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Atrophy
  • Blood Glucose / analysis
  • Dogs
  • Glucagon / administration & dosage
  • Glucagon / pharmacology*
  • Infusions, Parenteral
  • Insulin / administration & dosage
  • Insulin / deficiency
  • Insulin / pharmacology*
  • Liver / cytology*
  • Liver / pathology
  • Liver Diseases / etiology
  • Liver Diseases / pathology
  • Liver Diseases / prevention & control
  • Liver Regeneration / drug effects
  • Portacaval Shunt, Surgical* / adverse effects
  • Portal Vein

Substances

  • Blood Glucose
  • Insulin
  • Glucagon